GLP-1s — which lower blood sugar to help people lose weight — are taking the healthcare industry by storm and have several implications for digital health companies. This includes headwinds for ...

MALAGA, Spain—Patients with obesity treated with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy; Novo Nordisk) can achieve weight loss in the real world similar to what has ...

Connected fitness company Tonal has raised $45 million in Series C funding, bringing the company’s total funding to $90 million. The Growth Fund of L Catterton led the round. Additional investors ...

Obesity affects more than a quarter of the UK population and while around four million people could be eligible for NHS Specialist Weight Management Services each year, current capacity is limited to ...